• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    47.65 Down 0.17(0.36%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 286,758   269,264   210,812  
    Cost of Revenue29,058  21,144  13,469  
    Gross Profit 257,700   248,120   197,343  
    Operating Expenses
    Research Development230,743  218,627  170,297  
    Selling General and Administrative104,320  92,354  84,300  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (77,363) (62,861) (57,254)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,222  341  3,472  
    Earnings Before Interest And Taxes(76,141)(62,520)(53,782)
    Interest Expense -   -   -  
    Income Before Tax(76,141)(62,520)(53,782)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(76,141)(62,520)(53,782)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (76,141) (62,520) (53,782)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (76,141) (62,520) (53,782)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.